What is the ICD-10 (International Classification of Diseases, 10th Revision) code for a mycotic aneurysm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Code for Mycotic Aneurysm

The ICD-10 code for mycotic aneurysm is I72.9 (aneurysm of unspecified site) or more specifically I77.0 (arteriovenous fistula, acquired), though the most accurate coding depends on the anatomic location and whether the aneurysm is ruptured or intact.

Anatomic Location-Specific Coding

The ICD-10 coding system requires specification by anatomic site for mycotic aneurysms:

Intracranial Mycotic Aneurysms

  • I67.1 - Cerebral aneurysm, nonruptured
  • I60.x - Nontraumatic subarachnoid hemorrhage (if ruptured)
  • Intracranial mycotic aneurysms represent 0.7% to 6.5% of all intracranial aneurysms and are most commonly located in the middle cerebral artery (44% of cases) 1, 2

Thoracic and Abdominal Aortic Mycotic Aneurysms

  • I71.2 - Thoracic aortic aneurysm, without rupture
  • I71.1 - Thoracic aortic aneurysm, ruptured
  • I71.4 - Abdominal aortic aneurysm, without rupture
  • I71.3 - Abdominal aortic aneurysm, ruptured
  • Aortic mycotic aneurysms account for 30-40% of all mycotic aneurysms, with infrarenal location representing 15-25% and suprarenal location 5-15% 1

Peripheral Mycotic Aneurysms

  • I72.3 - Aneurysm of iliac artery
  • I72.4 - Aneurysm of artery of lower extremity
  • I72.1 - Aneurysm of artery of upper extremity
  • Peripheral mycotic aneurysms occur in approximately 1.9% of infective endocarditis cases 3

Critical Coding Considerations

Distinguish from Syphilitic Aneurysms

  • A52.01 should be used for syphilitic aneurysms, which are pathophysiologically distinct from acute mycotic aneurysms despite historical nomenclature confusion 4
  • Syphilitic aneurysms develop 10-25 years after initial infection and predominantly affect the ascending thoracic aorta as fusiform aneurysms, unlike the saccular, irregular morphology of mycotic aneurysms 4

Additional Codes for Associated Conditions

  • I33.0 - Acute and subacute infective endocarditis (present in many mycotic aneurysm cases) 3
  • B95-B97 - Bacterial and viral infectious agents (to specify causative organism when known)
  • Common organisms include Staphylococcus aureus, Salmonella species, Streptococcus pneumoniae, and Pseudomonas aeruginosa 5, 6

Documentation Requirements for Accurate Coding

To ensure proper ICD-10 code assignment, clinical documentation must specify:

  • Exact anatomic location (intracranial, thoracic aorta, abdominal aorta, peripheral vessel) 1
  • Rupture status (intact, contained rupture, or free rupture) - critical as rupture carries 85% mortality in some series 6
  • Associated infectious etiology when identified through blood cultures (positive in 50-90% of cases) or tissue cultures 1
  • Imaging characteristics including saccular morphology, periaortic soft tissue stranding, absence of calcification, and rapid enlargement on serial imaging 1

Common Coding Pitfalls

  • Avoid using I72.9 (aneurysm of unspecified site) when the anatomic location is documented, as this represents incomplete coding 1
  • Do not confuse with atherosclerotic aneurysms - mycotic aneurysms typically show lobular/irregular/saccular shape, minimal calcification, and periaortic inflammatory changes on CT imaging 1
  • Remember to code complications separately including hemorrhage, septic emboli (present in higher frequency with mycotic aneurysms), and multiple embolisms 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.